Hemostatic system parameters and level of magnesium in patients with beta-thalassemiа
- Authors: Aliyeva NR1
-
Affiliations:
- Scientific research institute of hematology and blood transfusion named after B. Eyvazov
- Issue: Vol 101, No 2 (2020)
- Pages: 188-192
- Section: Theoretical and clinical medicine
- URL: https://journals.rcsi.science/kazanmedj/article/view/26273
- DOI: https://doi.org/10.17816/KMJ2020-188
- ID: 26273
Cite item
Full Text
Abstract
Aim. To study the hemostatic system parameters and magnesium levels in patients with beta-thalassemia.
Methods. The object of the study was the blood serum of 96 women with beta-thalassemia: 46 patients with intermediate beta-thalassemia and 50 patients with beta-thalassemia minor, without clinical manifestations of hypercoagulation. The blood serum of 30 healthy donors was used as the control group. It was studied hemostasis system parameters: platelet count activated partial thromboplastin time (aPTT), prothrombin time, plasma fibrinogen level, D-dimer level, euglobulin clot lysis time, antithrombin III activity. The serum magnesium level and risk of deficiency were determined using the MDQ questionnaire.
Results. In patients with intermediate beta-thalassemia, an increase in the level of thrombinemia marker D-dimer (>500 ng/ml) was revealed. Patients with intermediate beta-thalassemia were divided into two groups according to the revealed level of D-dimer: 14 (30.4±6.8%) patients with latent hypercoagulation in group 1 and 32 (69.6±6.8%) patients without latent hypercoagulation in group 2. It was found that in the group with a high levels D-dimer, fibrinogen level was increased (p <0.05), fibrinolysis time was prolonged (p <0.05), activated partial thromboplastin time was shortened (p <0.05), and antithrombin III activity was slightly reduced (p >0.05). The serum magnesium level in patients of the first group was lower (t=7.3; p <0.001), and the risk of deficiency in the questionnaire was higher than in patients of the second group (r=–0.785, p <0.05). Hemostasis and magnesium levels in patients with beta-thalassemia minor did not differ from the control group (p >0.05).
Conclusion. One-third of patients with intermediate beta-thalassemia have a pre-thrombotic state for hemostasis — latent hypercoagulation and magnesium deficiency which can be predictors of clinical signs of thrombosis.
Full Text
##article.viewOnOriginalSite##About the authors
N R Aliyeva
Scientific research institute of hematology and blood transfusion named after B. Eyvazov
Author for correspondence.
Email: doktor.narqiz@mail.ru
Azerbaijan, Baku, Azerbaijan
References
- Cappellini M.D., Musallam K.M., Taher A.T. Тhalassemia as a hypercoagulable state. US Oncol. Hematol. 2011; 7: 157‒160. doi: 10.17925/OHR.2011.07.2.157.
- Cappellini M.D., Motta I., Musallam K.M., Taher A.T. Redefining thalassemia as a hypercoagulable state. Ann. NY Acad. Sci. 2010; 120: 231‒236. doi: 10.1111/j.1749-6632.2010.05548.x.
- Vorobev A.I., Vasilev S.A., Qorodezkij V.M. et al. Hypercoagulation syndrome: classification, pathogenesis, diagnostics, and therapy. Gematoloqiya i transfuziologiya. 2016; (3): 116–122. (In Russ.) doi: 10.18821/0234-5730-2016-61-3-116-122.
- Momot A.P. The problem of thrombophilia in clinical practice. Rossijskij zhurnal detskoj gematologii i onkologii. 2015; (1): 36–48. (In Russ.) doi: 10.17650/2311-1267-2015-1-36-48.
- Kopina M.N., Gaevskij Yu.G. Hypercoagulability disorders in patients with newly diagnosed iron deficiency anemia. Vestnik Novgorodskogo gosudarstvennogo universiteta. 2013; 1 (71): 21–24. (In Russ.)
- Kerimov A.A. Latent hypercoagulability disorders. Sovremennye dostizheniya azerbajdzhanskoj mediciny. 2014; (4): 116–122. (In Russ.)
- Gromova O.A., Kalacheva A.G., Torshin I.Yu. et al. Magnesium deficiency — a significant risk factor for comorbidity: results of large-scale screening of magnesium status in russian regions. Farmateka. 2013; (6): 16–28. (In Russ.)
- Kerimov A., Alieva N., Mamedova T., Qafarova S. The value of the level of magnesium in hemostasis patients beta-thalassemia. Biomedisina (Baku). 2016; (1): 15–19. (In Russ.)
- Andriadze N.A., Kobalava M.A. Increased risk of platelet thrombosis stimulated by hypomagnesiemia in acute myocardial infarction. Rossijskij kardiologicheskij zhurnal. 2004; (6): 14–17. (In Russ.) doi: 10.15829/1560-4071-2004-6-14-17.
- Barkagan Z.S., Momot A.P. Diagnostics and controlled therapy of violations of a hemostasis. Moscow: Nyu-Diamed. 2008; 292 р. (In Russ.)
- Serov V.N., Blinov D.V., Zimovina U.V., Dzhobava E.M. Results of an investigation of the prevalence of magnesium deficiency in pregnant women. Akusherstvo i ginekologiya. 2014; (6): 33–40. (In Russ.)
- Gromova O.A., Kalachova A.G., Torshin I.Y. On the diagnosis of magnesium deficiency. Part 1. Arxiv vnutrenney meditsini. 2014; (2): 5–10. (In Russ.) doi: 10.20514/2226-6704-2014-0-2-5-10.
- Cappelini M.D., Poggiali E., Taher S. et al. Hypercoagulolity in beta-thalassemia — a status quo. Expert. Rev. Hematol. 2012; 5: 505–512. doi: 10.1586/ehm.12.42.
